PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors

NCT07510828 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors

Interventions

BIOLOGICAL: EB-PT-CAR-NK-S
BIOLOGICAL: EB-PT-CAR-NK-D
DRUG: Lymphodepleting chemotherapy
DRUG: Cytokine support

Sponsor

Beijing Biotech